# Prevention of Arrhythmia Device Infection Trial (PADIT)

> **NCT01613092** · PHASE4 · COMPLETED · sponsor: **Population Health Research Institute** · enrollment: 241 (actual)

## Conditions studied

- Arrhythmia

## Interventions

- **DRUG:** Incremental
- **DRUG:** Cefazolin

## Key facts

- **NCT ID:** NCT01613092
- **Lead sponsor:** Population Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2013-11
- **Final completion:** 2013-12
- **Target enrollment:** 241 (ACTUAL)
- **Last updated:** 2014-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01613092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01613092, "Prevention of Arrhythmia Device Infection Trial (PADIT)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01613092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*